ArticleThe Journal of allergy and clinical immunology2023

Type 2 inflammation drives an airway basal stem cell program through insulin receptor substrate signaling.

Xin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.